Atlas Trials

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

Clinical trial NCT00237224 · COMPLETED

Trial details

NCT number
NCT00237224
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Cancer
Start date
2003-02-01
Primary completion
2007-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.